Pre-operative CYFRA 21-1 levels in patient with lung cancer: Correlation with mediastinal lumph node involvement [4]

European Journal of Cancer

Volumn 34, Issue 9, 1998, Pages 1469-1470

  Satoh, H ^a   Ishikawa, S ^a   Kamma, H ^a   Ohtsuka, M ^a   Hasegawa, S ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19 FRAGMENT;

CORRELATION FUNCTION; DIAGNOSTIC VALUE; HUMAN; LETTER; LUNG CANCER; LYMPH NODE METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; HUMANS; KERATINS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINUM; TUMOR MARKERS, BIOLOGICAL;

EID: 0032146034     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. 1. Stieber P, Hasholzner U, Bodenmüller H, et al. CYFRA 21-1: a new marker in lung cancer. Cancer 1993, 72, 707-713.
2. 2. Pujol JL, Grenier J, Daurés JP, et al. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1. Immunoradiometric assay as a marker of lung cancer. Cancer Res 1993, 53, 61-66.
3. 3. Rastel D, Ramaioli A, Cornillie F, Thirion B. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. Eur J Cancer 1994, 30A, 601-606.
4. 4. Takada M, Masuda N, Matsuura E, et al. Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. Br J Cancer 1995, 71, 160-165.
5. 5. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997, 111, 1710-1717.